Snowball logo
logo
CMOP

Cosmo Pharmaceuticals N.V

CMOPF β€’ PINK
$63.317-$0.683Β  (1.07%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
57.21102.192.78266.8104.8284.7
COGS
13.3118.7639.3419.8656.0578.07
Gross Profit
43.983.3353.44246.948.77206.6
Operating Expenses & Income
Operating Income
9.75888928.066.146148.9(10.48)46.84
Total Operating Expenses
18.4655.2747.2998.0459.25159.8
R&D Expenses
9.98393915.5318.810.37332.2959.67
Selling General & Admin Expenses
2.1704983.1315.3016.4590.0636.459
Earnings from Continuing Operations
Interest Expense
(7.903109)(9.159)(8.526)(0.125867)(0.182126)(0.355514)
Interest Income
2.6918042.9414.0681.6691.057-
Income Tax Expense
2.0483036.9686.26420.182.58802411
Net Income
Net Income
19.0517.23(4.932)133.2(3.630478)48.92
Supplemental
EBIT
9.75888933.636.146153.4(10.48)51.38
EBITDA
16.2447.4918165.72.27611275.69
In millions of USD, except % and values per 1 share